VRDNViridian Therapeutics, Inc.

NASDAQ · Utilities · Large Cap · Mkt cap $214.6B · Vol 17.84M

$13.22

▲ +4.69% today

Fetching live price…

🏛️ Member of:Russell 2000

God's Eye forensics

Accounting quality and solvency screens. Anything that can't be computed from available filings data is left blank rather than estimated.

Piotroski F-Score

5/5

5

5 of 5 financial-health checks passed (4 checks need data this provider doesn't publish).

Altman Z-Score

Insufficient data

—

Needs total assets, operating profit and debt — not published for this listing yet.

Beneish (earnings quality)

Insufficient data

—

The full manipulation model needs two years of receivables, depreciation and accrual data, which isn't published for this listing.

Scores are free. The criteria-by-criteria breakdown — exactly which checks this company failed — is part of DeepScreen Pro.

Fundamental breakdown — raw ratios are free · fetching live data — showing modeled estimates for now

P/E Ratio (TTM)

Modeled

6.2x

Cheap vs. earnings

Contextual insight — DeepScreen Pro

PEG Ratio

Modeled

0.46

Undervalued vs. growth

Contextual insight — DeepScreen Pro

P/S Ratio

Modeled

0.51x

Modest sales multiple

Contextual insight — DeepScreen Pro

P/B Ratio

Modeled

1.81x

Reasonable

Contextual insight — DeepScreen Pro

EV/Revenue

Modeled

0.54x

Low (value zone)

Contextual insight — DeepScreen Pro

EV/EBITDA

Modeled

3.1x

Attractive

Contextual insight — DeepScreen Pro

ROE

Modeled

29.2%

Excellent shareholder returns

Contextual insight — DeepScreen Pro

ROA

Modeled

15.3%

Assets working hard

Contextual insight — DeepScreen Pro

ROCE

Modeled

20.4%

High-quality compounder

Contextual insight — DeepScreen Pro

Debt / Equity

Modeled

0.56x

Manageable

Contextual insight — DeepScreen Pro

LT Debt / Equity

Modeled

0.44x

Moderate long-term leverage

Contextual insight — DeepScreen Pro

Payout Ratio

Modeled

30%

Ideal balance — sustainable with room to reinvest

Contextual insight — DeepScreen Pro

Operating Leverage

Modeled

2.77x

Profits amplify — both ways

Contextual insight — DeepScreen Pro

Company financials

EPS (TTM): $2.13
Revenue (TTM): $420.8B
Net margin: 8.2%
EBITDA margin: 17.3%
Earnings growth: 13.4%
Dividend yield: 4.84%
Payout ratio: 30%
Debt / equity: 0.56x

Live data hasn't loaded yet — figures shown are DeepScreen's modeled estimates.

VRDN live news

LIVE

Loading live headlines…